Perindopril Erbumine (Lannett Company, Inc.)
Welcome to the PulseAid listing for the Perindopril Erbumine drug offered from Lannett Company, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lannett Company, Inc. |
| NON-PROPRIETARY NAME: | Perindopril Erbumine |
| SUBSTANCE NAME: | PERINDOPRIL ERBUMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Perindopril Erbumine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Perindopril Erbumine from Lannett Company, Inc. |
| LABELER NAME: | Lannett Company, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/1) |
| START MARKETING DATE: | 2014-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0527-1919_3c07919a-a38c-4a38-a761-65196c8c7883 |
| PRODUCT NDC: | 0527-1919 |
| APPLICATION NUMBER: | NDA020184 |
Other PERINDOPRIL ERBUMINE Pharmaceutical Manufacturers / Labelers:
